Zymeworks (ZYME) Non-Current Deffered Revenue (2021 - 2023)
Historic Non-Current Deffered Revenue for Zymeworks (ZYME) over the last 3 years, with Q3 2023 value amounting to $32.9 million.
- Zymeworks' Non-Current Deffered Revenue changed 0.0% to $32.9 million in Q3 2023 from the same period last year, while for Sep 2023 it was $32.9 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $30.6 million for FY2022, which is 714.31% down from last year.
- As of Q3 2023, Zymeworks' Non-Current Deffered Revenue stood at $32.9 million, which was down 0.0% from $30.6 million recorded in Q2 2023.
- Zymeworks' Non-Current Deffered Revenue's 5-year high stood at $32.9 million during Q4 2021, with a 5-year trough of $30.6 million in Q4 2022.
- Over the past 3 years, Zymeworks' median Non-Current Deffered Revenue value was $31.8 million (recorded in 2021), while the average stood at $31.8 million.
- As far as peak fluctuations go, Zymeworks' Non-Current Deffered Revenue tumbled by 714.31% in 2022, and later changed by 0.0% in 2023.
- Over the past 3 years, Zymeworks' Non-Current Deffered Revenue (Quarter) stood at $32.9 million in 2021, then dropped by 7.14% to $30.6 million in 2022, then rose by 7.69% to $32.9 million in 2023.
- Its last three reported values are $32.9 million in Q3 2023, $30.6 million for Q2 2023, and $30.6 million during Q1 2023.